Reunion Neuroscience Inc. Common Shares
REUN
REUN was delisted on the 31st of July, 2023.
27 hedge funds and large institutions have $12.2M invested in Reunion Neuroscience Inc. Common Shares in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 8 closing their positions.
10% less funds holding
Funds holding: 30 → 27 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
49% less capital invested
Capital invested by funds: $23.9M → $12.2M (-$11.6M)
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$3.08M |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$211K |
| 3 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$145K |
| 4 |
Millennium Management
New York
|
+$65.2K |
| 5 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$22.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.89M |
| 2 |
O
OrbiMed
New York
|
-$1.6M |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$441K |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$381K |
| 5 |
Morgan Stanley
New York
|
-$181K |
REUN Hedge Fund Activity: Q1 2022 in Review
27 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q1 2022, worth a combined $12.2M — down 49% from $23.9M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of REUN and 5 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 4 added.
The largest buyer was DAFNA Capital Management, adding an estimated $3.08M. The largest seller was Point72 Asset Management, cutting an estimated $1.89M.
- 27 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q1 2022, down from 30 in Q4 2021.
- Funds reported $12.2M of Reunion Neuroscience Inc. Common Shares stock for Q1 2022, down 49% quarter-over-quarter.
- 5 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q1 2022 and 8 closed out, a net change of -3 holders.
- The largest Reunion Neuroscience Inc. Common Shares buyer in Q1 2022 was DAFNA Capital Management, an estimated $3.08M added.
- The largest Reunion Neuroscience Inc. Common Shares seller in Q1 2022 was Point72 Asset Management, an estimated $1.89M sold.
Based on aggregated 13F filings for Q1 2022.